Patient volume at radiation therapy clinics can affect outcomes, and experts call attention to a third breast cancer gene, PALB2.

by Marci A. Landsmann

Survival is not affected by delaying breast cancer treatment for fertility preservation, and the FDA approves a drug combination to treat kidney cancer.

by Kevin McLaughlin

People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.

by Pamela Rafalow Grossman

Healthy lifestyle habits can reduce risk of cancer, and less treatment may be adequate for some children with ALL.

by Marci A. Landsmann

Two studies on access to opioids identify disturbing patterns, and Keytruda before and after surgery helps some breast cancer patients.

by Kevin McLaughlin

After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs' value for cancer patients undergoing treatment.

by Jon Kelvey

A study measures the global impact of alcohol on cancer incidence, and the FDA approves treatments for multiple myeloma and urothelial cancer.

by Bradley Jones

The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.

by Marcus A. Banks

A study sheds light on the link between red meat consumption and colorectal cancer, and mRNA COVID-19 vaccines are effective in most cancer patients.

by Kevin McLaughlin

The rapid development of mRNA COVID-19 vaccines could spark advances in similar treatments for cancer.

by Stephen Ornes